|Articles|June 25, 2015 (Updated: November 15, 2020)
Outlook: Market Access in Australia
Despite recent challenges, the Australian market still offers a number of opportunities for pharma manufacturers.
Advertisement
Australia is a country that has challenged pharmaceutical manufacturers in recent years with extensive government reforms in drug pricing, unpredictability around reimbursement and pricing decisions, and other structural changes. Despite these challenges, the Australian market still offers a number of opportunities for manufacturers.
This
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Launches Employer Connect Platform Offering Obesity Coverage Options
2
Pharmaceutical Executive Daily: Pharma Industry's AI Adoption
3
The Ongoing Impact of MFN Pricing
4
AI's Inflection Point: Bridging the Adoption and ROI Gap
5